Evidence map›Paper›PMID 29921958›Full record

ArticleNature medicine2018

Author Correction: STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis.

Neibla Priego, Lucía Zhu, Cátia Monteiro, Manon Mulders, David Wasilewski, Wendy Bindeman, Laura Doglio, Liliana Martínez, Elena Martínez-Saez, Santiago Ramón Y Cajal and 16 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Treating Metastatic Brain Cancers With Stem Cells.Frontiers in molecular neuroscience · 2021
    Review
  7. Brain metastasis.Nature reviews. Cancer · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Neibla PriegoBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Lucía ZhuBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Cátia MonteiroBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Manon MuldersBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
David WasilewskiBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Wendy BindemanBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Laura DoglioBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Liliana MartínezBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Elena Martínez-SaezPathology Department, Vall d'Hebron Hospital, Barcelona, Spain.
Santiago Ramón Y CajalPathology Department, Vall d'Hebron Hospital, Barcelona, Spain.
Diego MegíasConfocal Microscopy Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Elena Hernández-EncinasExperimental Therapeutics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Carmen Blanco-AparicioExperimental Therapeutics Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Lola MartínezFlow Cytometry Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Eduardo ZarzuelaProteoRed-ISCIII. Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Javier MuñozProteoRed-ISCIII. Proteomics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Coral Fustero-TorreBioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Elena Piñeiro-YáñezBioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Aurelio Hernández-LaínNeuropathology Unit, Hospital Universitario 12 de Octubre Research Institute, Madrid, Spain.
Luca BerteroMedical Sciences Department, Division of Pathology, University and City of Health and Science University Hospital of Turin, Turin, Italy.ORCID http://orcid.org/0000-0001-9887-7668
Valeria PoliMolecular Biotechnology Centre, University of Turin, Turin, Italy.ORCID http://orcid.org/0000-0002-3739-3966
Melchor Sanchez-MartinezMind the Byte, Barcelona, Spain.
Javier A MenendezProgram Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.
Riccardo SoffiettiNeuro-Oncology Department, University and City of Health and Science University Hospital of Turin, Turin, Italy.
Joaquim Bosch-BarreraMolecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.ORCID http://orcid.org/0000-0002-0893-7821
Manuel ValienteBrain Metastasis Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. mvaliente@cnio.es.ORCID http://orcid.org/0000-0002-0647-7542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the version of this article originally published, the names of three authors were incorrect. The authors were listed as "Coral Fustero-Torres", "Elena Pineiro" and "Melchor Sánchez-Martínez". Their respective names are "Coral Fustero-Torre", "Elena Piñeiro-Yáñez" and "Melchor Sanchez-Martinez". The errors have been corrected in the print, HTML and PDF versions of this article.

Identifiers

PMID29921958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.